{"pmid":32462695,"title":"Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.","text":["Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a global pandemic and remains as a major public health issue This article is protected by copyright. All rights reserved.","J Med Virol","Li, Zheng-Tu","Chen, Zhao-Ming","Chen, Ling-Dan","Zhan, Yang-Qing","Li, Shao-Qiang","Cheng, Jing","Zhu, Ai-Ru","Chen, Li-Yan","Zhong, Nan-Shan","Li, Shi-Yue","Lu, Wen-Ju","Ye, Feng","32462695"],"abstract":["The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a global pandemic and remains as a major public health issue This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Li, Zheng-Tu","Chen, Zhao-Ming","Chen, Ling-Dan","Zhan, Yang-Qing","Li, Shao-Qiang","Cheng, Jing","Zhu, Ai-Ru","Chen, Li-Yan","Zhong, Nan-Shan","Li, Shi-Yue","Lu, Wen-Ju","Ye, Feng"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462695","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26073","locations":["China","Guangzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1668079521189855232,"score":9.490897,"similar":[{"pmid":32470211,"title":"Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?","text":["Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?","We have recently read the article by Chaung et al.,(1) describing a case of SARS-CoV-2 and HCoV-HKU1 coinfection. The HCoV-HKU1 is also a member of the Betacoronavirus. This article is protected by copyright. All rights reserved.","J Med Virol","Sanchez-Duque, Jorge A","Orozco-Hernandez, Juan Pablo","Marin-Medina, Daniel S","Cvetkovic-Vega, Aleksandar","Aveiro-Robalo, Telmo Raul","Mondragon-Cardona, Alvaro","Failoc-Rojas, Virgilio E","Gutierrez-Ocampo, Estefania","Villamizar-Pena, Rhuvi","Henao-Martinez, Juan F","Arteaga-Livias, Kovy","Rodriguez-Morales, Alfonso J","32470211"],"abstract":["We have recently read the article by Chaung et al.,(1) describing a case of SARS-CoV-2 and HCoV-HKU1 coinfection. The HCoV-HKU1 is also a member of the Betacoronavirus. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Sanchez-Duque, Jorge A","Orozco-Hernandez, Juan Pablo","Marin-Medina, Daniel S","Cvetkovic-Vega, Aleksandar","Aveiro-Robalo, Telmo Raul","Mondragon-Cardona, Alvaro","Failoc-Rojas, Virgilio E","Gutierrez-Ocampo, Estefania","Villamizar-Pena, Rhuvi","Henao-Martinez, Juan F","Arteaga-Livias, Kovy","Rodriguez-Morales, Alfonso J"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470211","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26089","topics":["Diagnosis"],"weight":1,"_version_":1668167110009815040,"score":111.383156},{"pmid":32379350,"title":"Complete title: Codon bias analysis may be insufficient for identifying host(s) of a novel virus.","text":["Complete title: Codon bias analysis may be insufficient for identifying host(s) of a novel virus.","A novel kind of coronavirus has infected more than 1, 600, 000 people, claimed over 100, 000 lives, and spread to 212 countries and territories since December 2019.(1) The virus has been named SARS-CoV-2 (provisionally termed 2019-nCoV before(2) ), and the pneumonia caused by it is COVID-19. Though many scientists and researchers are trying to identify the animals harboring SARS-CoV-2, the intermediate host remains under the veil. This article is protected by copyright. All rights reserved.","J Med Virol","Gong, Yuzhou","Wen, Guannan","Jiang, Jianping","Feng, Xie","32379350"],"abstract":["A novel kind of coronavirus has infected more than 1, 600, 000 people, claimed over 100, 000 lives, and spread to 212 countries and territories since December 2019.(1) The virus has been named SARS-CoV-2 (provisionally termed 2019-nCoV before(2) ), and the pneumonia caused by it is COVID-19. Though many scientists and researchers are trying to identify the animals harboring SARS-CoV-2, the intermediate host remains under the veil. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Gong, Yuzhou","Wen, Guannan","Jiang, Jianping","Feng, Xie"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379350","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/jmv.25977","topics":["Mechanism","Transmission"],"weight":1,"_version_":1666597097270411264,"score":108.88489},{"pmid":32081636,"pmcid":"PMC7127800","title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.","text":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond.","Int J Antimicrob Agents","Lai, Chih-Cheng","Shih, Tzu-Ping","Ko, Wen-Chien","Tang, Hung-Jen","Hsueh, Po-Ren","32081636"],"abstract":["The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond."],"journal":"Int J Antimicrob Agents","authors":["Lai, Chih-Cheng","Shih, Tzu-Ping","Ko, Wen-Chien","Tang, Hung-Jen","Hsueh, Po-Ren"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32081636","source":"PubMed","week":"20208|Feb 17 - Feb 23","doi":"10.1016/j.ijantimicag.2020.105924","keywords":["2019-ncov","covid-19","china","epidemic","remdesivir","sars-cov-2"],"locations":["China","China","Wuhan","USA","China"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"e_drugs":["remdesivir"],"topics":["Prevention","Transmission","Treatment"],"weight":1,"_version_":1666138492944515074,"score":90.158356},{"pmid":32270884,"title":"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","text":["Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","We read with great interest the study authored by Angeletti et al. regarding the role of nonstructural proteins nsp2 and nsp3 in the pathogenesis of COVID-19(1) . COVID-19 emerged in December 2019 in Wuhan City, Hubei Province, China and is caused by a novel viral variant belonging to the viral variant belonging to the Severe acute respiratory syndrome-related coronavirus (SARS-rCoV) species of subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae and named SARS-CoV-2(2) . This article is protected by copyright. All rights reserved.","J Med Virol","da Silva, Severino Jefferson Ribeiro","da Silva, Caroline Targino Alves","Mendes, Renata Pessoa Germano","Pena, Lindomar","32270884"],"abstract":["We read with great interest the study authored by Angeletti et al. regarding the role of nonstructural proteins nsp2 and nsp3 in the pathogenesis of COVID-19(1) . COVID-19 emerged in December 2019 in Wuhan City, Hubei Province, China and is caused by a novel viral variant belonging to the viral variant belonging to the Severe acute respiratory syndrome-related coronavirus (SARS-rCoV) species of subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae and named SARS-CoV-2(2) . This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["da Silva, Severino Jefferson Ribeiro","da Silva, Caroline Targino Alves","Mendes, Renata Pessoa Germano","Pena, Lindomar"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270884","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25858","locations":["Wuhan","Hubei","China","Sarbecovirus"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138491748089856,"score":89.13395},{"pmid":32234466,"pmcid":"PMC7139247","title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives.","text":["Coronavirus disease 2019 (COVID-19): current status and future perspectives.","Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [previously provisionally known as 2019 novel coronavirus (2019-nCoV)]. At present, the newly identified SARS-CoV-2 has caused a large number of deaths with tens of thousands of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19. Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies. Hence, this review will focus on recent progress regarding the structure of SARS-CoV-2 and the characteristics of COVID-19, such as the aetiology, pathogenesis and epidemiological characteristics.","Int J Antimicrob Agents","Li, Heng","Liu, Shang-Ming","Yu, Xiao-Hua","Tang, Shi-Lin","Tang, Chao-Ke","32234466"],"abstract":["Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China, and has spread quickly to 72 countries to date. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [previously provisionally known as 2019 novel coronavirus (2019-nCoV)]. At present, the newly identified SARS-CoV-2 has caused a large number of deaths with tens of thousands of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19. Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies. Hence, this review will focus on recent progress regarding the structure of SARS-CoV-2 and the characteristics of COVID-19, such as the aetiology, pathogenesis and epidemiological characteristics."],"journal":"Int J Antimicrob Agents","authors":["Li, Heng","Liu, Shang-Ming","Yu, Xiao-Hua","Tang, Shi-Lin","Tang, Chao-Ke"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234466","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijantimicag.2020.105951","keywords":["2019-ncov","covid-19","coronavirus","pneumonia","sars-cov-2"],"locations":["Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"_version_":1666138490238140419,"score":86.0469}]}